<!DOCTYPE html>
<!-- saved from url=(0031)https://demo-8cc0ce.webflow.io/ -->
<html data-wf-domain="demo-8cc0ce.webflow.io" data-wf-page="5eed512a154958a8ac01307f" data-wf-site="5eed512a154958e3fe01307e" lang="en-US" class="w-mod-js wf-montserrat-n4-active wf-montserrat-i4-active wf-montserrat-n6-active wf-montserrat-n7-active wf-montserrat-i7-active wf-raleway-n4-active wf-raleway-n7-active wf-montserrat-n1-active wf-montserrat-i1-active wf-montserrat-n2-active wf-montserrat-i2-active wf-montserrat-n3-active wf-montserrat-n5-active wf-montserrat-i3-active wf-montserrat-i5-active wf-montserrat-i6-active wf-montserrat-n8-active wf-montserrat-i8-active wf-montserrat-n9-active wf-montserrat-i9-active wf-raleway-n1-active wf-raleway-n2-active wf-raleway-n3-active wf-raleway-n5-active wf-raleway-n6-active wf-raleway-n8-active wf-raleway-n9-active wf-raleway-i1-active wf-raleway-i2-active wf-raleway-i3-active wf-raleway-i4-active wf-raleway-i5-active wf-raleway-i6-active wf-raleway-i7-active wf-raleway-i8-active wf-raleway-i9-active wf-active">

<head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><style>.wf-force-outline-none[tabindex="-1"]:focus{outline:none;}</style><title>Demo</title><meta content="width=device-width, initial-scale=1" name="viewport"><meta content="Webflow" name="generator"><link href="./Demo_files/demo-8cc0ce.webflow.shared.4e2d363ab.min.css" rel="stylesheet" type="text/css"><link href="https://fonts.googleapis.com/" rel="preconnect"><link href="https://fonts.gstatic.com/" rel="preconnect" crossorigin="anonymous"><script src="./Demo_files/webfont.js.download" type="text/javascript"></script><style type="text/css" id="operaUserStyle"></style><link rel="stylesheet" href="./Demo_files/css" media="all"><script type="text/javascript">WebFont.load({  google: {    families: ["Montserrat:100,100italic,200,200italic,300,300italic,400,400italic,500,500italic,600,600italic,700,700italic,800,800italic,900,900italic","Raleway:regular","Raleway:100,200,300,regular,500,600,700,800,900,100italic,200italic,300italic,italic,500italic,600italic,700italic,800italic,900italic"]  }});</script><script type="text/javascript">!function(o,c){var n=c.documentElement,t=" w-mod-";n.className+=t+"js",("ontouchstart"in o||o.DocumentTouch&&c instanceof DocumentTouch)&&(n.className+=t+"touch")}(window,document);</script><link href="favicon.ico" rel="shortcut icon" type="image/x-icon"></head>

<body class="body"><div data-animation="default" data-collapse="tiny" data-duration="400" data-easing="ease" data-easing2="ease" role="banner" class="navbar w-nav"><div class="div-block-5"><img src="./Demo_files/65df768706a2cb62049b0ee7_Snipaste_2024-02-28_10-06-29.png" loading="lazy" sizes="(max-width: 639px) 100vw, 639px" srcset="https://cdn.prod.website-files.com/5eed512a154958e3fe01307e/65df768706a2cb62049b0ee7_Snipaste_2024-02-28_10-06-29-p-500.png 500w, https://cdn.prod.website-files.com/5eed512a154958e3fe01307e/65df768706a2cb62049b0ee7_Snipaste_2024-02-28_10-06-29.png 639w" alt="" class="logo"></div><div class="w-layout-blockcontainer tab w-container"><a href="https://demo-8cc0ce.webflow.io/#" class="tab-button w-button">PUBLICATIONS</a><a href="https://demo-8cc0ce.webflow.io/#" class="tab-button w-button">GALLERY</a><a href="https://demo-8cc0ce.webflow.io/#" class="tab-button w-button">HOME</a></div><div class="menu-button w-nav-button" style="-webkit-user-select: text;" aria-label="menu" role="button" tabindex="0" aria-controls="w-nav-overlay-0" aria-haspopup="menu" aria-expanded="false"><div class="tab-icon w-icon-nav-menu"></div></div><div class="w-nav-overlay" data-wf-ignore="" id="w-nav-overlay-0"></div></div><section class="section-2"><div id="w-node-_1d059831-0963-9f5b-8fa7-bb02f7932ad8-ac01307f" class="w-layout-layout quick-stack wf-layout-layout"><div class="w-layout-cell cell-4"></div><div class="w-layout-cell cell"><div class="w-layout-hflex flex-block w-clearfix"><h3 class="publication-h3">Publications</h3><p class="paragraph">* correponding author; # co-first author</p></div><h4 class="publication-year">2023</h4><div class="w-layout-blockcontainer container-3 w-container"><div class="paper-list">1. <strong>J Hu</strong>, P Tan, M Ishihara, NA Bailey, S Schokrpur, J G Reynoso, Y Zhang, R J Lim, C Dumitras, L Yang, S MDubinett, &nbsp;P S Jat, J Van Snick, J Huang,A I Chin, R M Prins, T G Graeber, H Xu* and L Wu*, <strong><em>Tumor Heterogeneity in VHL Drives Metastasis in Clear Cell Renal CellCarcinoma</em></strong>, Signal Transduction and Targeted Therapy, 2023, 8, (1), 155</div><div class="paper-list">2. <strong>J Hu*</strong>, D J Smithand L Wu*, <strong><em>VHL L169P Variant Does Not Alter Cellular Hypoxia Tension in ClearCell Renal Cell Carcinoma</em></strong>. Int. J. Mol. Sci., 2023, 24,(18), 14075.</div><div class="paper-list">3. K Flora, M Ishihara, Z Zhang, E S.Bowen, A Wu, T Ayoub, J Huang, C Cano-Ruiz, M Jackson, K Reghu, Y Ayoub, YZ Zhu, HR Tseng, ZH Hong, <strong>J Hu*</strong> and L Wu*. <strong><em>Exosomesfrom Von Hippel-Lindau-Null Cancer Cells Promote Metastasis in Renal CellCarcinoma</em></strong>. Int. J. Mol. Sci.. 2023, 24(24), 17307.</div><div class="paper-list">4. N Sun,C Zhang, YT Lee, BV Tran, J Wang, H Kim, J Lee, RY Zhang, JJ Wang, <strong>J Hu</strong>,Z Zhang, MS Alsudaney, KC Hou, H Tang, TX Zhang, IY Liang, Z Zhou, M Chen, AHYeh, W Li, XJ Zhou, HR Chang, SB Han, S Sadeghi, RS Finn, S Saab, RW Busuttil, MNoureddin, WS Ayoub, A Kuo, V Sundaram, B Al-Ghaieb, J Palomique, K Kosari, IKKim, T Todo, NN Nissen, ML Tomasi, S You, EM Posadas, JX Wu, M Wadehra, MS Sim,Y Li, HL Wang, SW French, SC Lu, L Wu, R Pei, L Liang, JD Yang, VG Agopian, HR Tseng,Y Zhu. <strong><em>HCC EV ECG score: An extracellular vesicle-based protein assay fordetection of early-stage hepatocellular carcinoma</em><em>. </em></strong>Hepatology. 2023 Mar 1;77(3):774-788.</div></div><h4 class="publication-year">2022</h4><div class="w-layout-blockcontainer container-3 w-container"><div class="paper-list">1. &nbsp;Z Zhang, <strong>J Hu</strong>, M Ishihara, AC Sharrow, K Flora, Y He, L Wu, <strong><em>The miRNA-21-5p Payload in Exosomes from M2 Macrophages Drives Tumor Cell Aggression via PTEN/Akt Signaling in Renal Cell Carcinoma</em></strong>. Int. J. Mol. Sci. 2022, 23, 3005.&nbsp;</div></div><h4 class="publication-year">2021</h4><div class="w-layout-blockcontainer container-3 w-container"><div class="paper-list">1. Z Zhang., G Ai, L Chen, S Liu, G Chen, X Zhu, C Zhang, H Qin, <strong>J Hu*</strong>, J Huang*, <strong><em>Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis.</em></strong> BMC Infect Dis 21, 738 (2021).</div><div class="paper-list">2. W Guan, F Li, Z Zhao,Z Zhang, <strong>J Hu</strong>, Y Zhang. <strong><em>Tumor-Associated Macrophage Promotes theSurvival of Cancer Cells upon Docetaxel Chemotherapy via theCSF1/CSF1R–CXCL12/CXCR4 Axis in Castration-Resistant Prostate Cancer</em></strong><em>.</em> Genes.2021;12(5):773 </div><div class="paper-list">3. &nbsp;M Gao#, H Wu#, R Plamthottam, Z Xie, Y Liu, <strong>J Hu</strong>, S Wu, L Wu, X He and Q Pei, <strong><em>Skin Temperature Triggered, Debonding-on-Demand Sticker for a Self-Powered Mechanosensitive Communication System</em></strong>, Matter, 2021</div><div class="paper-list">4. &nbsp;J Zeng, H Xu, C Huang, Y Sun, H Xiao, G Yu, H Zhou, Y Zhang, W Yao, W Xiao, <strong>J Hu</strong>, Lily Wu, J Xing, T Wang, Z Chen, Z Ye and K Chen, <strong><em>CD46 splice variant enhances translation of specific mRNAs linked to an aggressive tumor cell phenotype in bladder cancer</em></strong>. Mol Ther Nucleic Acids. 2021 Feb 24;24:140-153.</div><div class="paper-list">5. &nbsp;K Chen, J Zeng, Y Sun, W Ouyang, G Yu, H Zhou, Y Zhang, W Yao, W Xiao, <strong>J Hu</strong>, J Xing, K Xiao, L Wu, Z Chen, Z Ye and H Xu, <strong><em>Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma</em></strong>. Cancer Commun. 2021; 41: 316–332</div></div><h4 class="publication-year">2020</h4><div class="w-layout-blockcontainer container-3 w-container"><div class="paper-list">1. &nbsp;M Ishihara#, <strong>J Hu#</strong>, X Zhang, Y Choi, A Wong, C Cano-Ruiz, &nbsp; &nbsp; R Zhao, P Tan, J Tso, L Wu, <em>C</em><strong><em>omparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane</em></strong>, Journal of Visualized Experiments, 2020(156):e60314.</div><div class="paper-list">2. &nbsp;AC Sharrow, M. Ishihara, <strong>J. Hu</strong>, IH Kim, and L Wu.<em> </em><strong><em>Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers</em></strong><em>. Journal of Visualized Experiments, 2020(155):e60651.</em></div><div class="paper-list">3.. &nbsp;J Dong, RY Zhang, N Sun, <strong>J Hu</strong>, MD Smalley, A Zhou, Y Hua, W Rothermich, M Chen, J Chen, J Ye, P Teng, D Qi, JA Toretsky, JS Tomlinson, M Li, PS Weiss, SJ Jonas, N Federman, L Wu, M Zhao, HR Tseng, Y Zhu, <strong><em>Coupling Nanostructured Microchips with Covalent Chemistry Enables Purification of Sarcoma-Derived Extracellular Vesicles for Downstream Functional Studies</em></strong>. Advanced Functional Materials.2020 Sep 13: 2003237</div></div><h4 class="publication-year">2019</h4><div class="w-layout-blockcontainer container-3 w-container"><div class="paper-list paper-year-end">1. &nbsp;<strong>J Hu</strong>, W. Guan, L. Yan, Z. Ye, L. Wu, H. Xu, <strong><em class="italic-text">Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma</em></strong>. Stem Cells International, 2019: 9.</div><div class="paper-list">2. &nbsp;<strong>J Hu</strong>, M. Ishihara, A. I. Chin, L. Wu, <strong><em>Establishment of xenografts of urological cancers on chicken chorioallantoic membrane (CAM) to study metastasis</em>. </strong>Precis Clin Med<strong>,</strong> 2019;2(3):140-51.</div><div class="paper-list">3. &nbsp;W Guan#, <strong>J Hu#</strong>, L. Yang, P. Tan, Z. Tang, B. West, G. Bollag, H. Xu, and L. Wu,<em> </em><strong><em>Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer</em></strong><em>. </em>Endocrine Related Cancer, 2019. 26(1): p. 131-140.</div><div class="paper-list">4. &nbsp;L Yan, B Ding, H Liu, Y Zhang, J Zeng, <strong>J Hu</strong>, W Yao, G Yu, R An, Z Chen, Z Ye, J Xing, K Xiao, L Wu, H Xu, <strong><em>Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma</em></strong>. Theranostics. 2019;9(26):8377-8391. 2019 Oct 22.</div><div class="paper-list">5. H Zhou, K Tang, H Liu,J Zeng, H Li, L Yan, <strong>J Hu</strong>, W Guan, K Chen, H Xu, Z Ye, <strong><em>Regulatory Network of Two Tumor-Suppressive Noncoding RNAs Interferes with the Growth andMetastasis of Renal Cell Carcinoma</em></strong><em>.</em> Molecular Therapy - Nucleic Acids.2019; 16:554-65</div></div><h4 class="publication-year">2018</h4><div class="w-layout-blockcontainer container-3 w-container"><div class="paper-list">1. &nbsp;<strong>J Hu.</strong>, S. Schokrpur, M. Archang, K. Hermann, A. C. Sharrow, P. Khanna, J. Novak, S Signoretti, R.S. Bhatt, B.S. Knudsen, H. Xu, and L. Wu, <strong><em>A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model</em></strong>. Molecular Therapy - Methods &amp; Clinical Development, 9: 203, 2018</div></div><h4 class="publication-year">2017</h4><div class="w-layout-blockcontainer container-3 w-container"><div class="paper-list">1. <strong>J Hu</strong>, W Guan, P Liu, J Dai, K. Tang, H. Xiao, Y. Qian, A. C.Sharrow, Z. Ye, L. Wu, and H. Xu, <strong><em>Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in RenalCancer Stem Cells</em>. Stem Cell Reports</strong>, 2017. 9(2): p. 464-477</div><div class="paper-list">2. K Chen, J. Zeng, G. Yu, H. Zhou, C.Huang, W. Yao, W. Xiao, <strong>J Hu</strong>, W.Guan, L. Wu, J. Huang, Q. Huang, H. Xu and Z. Ye, <strong><em>Alternative splicing of EZH2 pre-mRNA by SF3B3 contributes to thetumorigenic potential of renal cancer</em></strong><em>.</em> Clinical Cancer Research, 2017 Jul 1;23(13):3428-3441.</div><div class="paper-list">3.&nbsp;T Yang,H. Zhou, P. Liu, L. Yan, W. Yao, K. Chen, J. Zeng, H. Li, <strong>J Hu</strong>, X. Hua, Z. Ye,<strong> <em>lncRNAPVT1 and its splicing variant function as competing endogenous RNA to regulateclear cell renal cell carcinoma progression</em></strong>. Oncotarget, 2017.8(49): p. 85353-85367.1.</div></div><h4 class="publication-year">2016</h4><div class="w-layout-blockcontainer container-3 w-container"><div class="paper-list">1. S Schokrpur,<strong>J Hu</strong>, D.L. Moughon, P. Liu, L.C.Lin, K. Hermann, S. Mangul, W. Guan, M. Pellegrini, and H. Xu, <strong>CRISPR-Mediated VHL Knockout Generates anImproved Model for Metastatic Renal Cell Carcinoma</strong>. Scientific Reports,2016. 6.</div><div class="paper-list">2. K Chen, J. Zeng, K. Tang, H. Xiao, J Hu, C. Huang, W. Yao, G. Yu, W. Xiao,and W. Guan, <strong><em>miR‐490‐5p suppresses tumour growth in renalcell carcinoma through targeting PIK3CA</em></strong><em>.</em> Biologyof the Cell, 2016. 108(2): p. 41-50. </div><div class="paper-list">3. K Chen, J. Zeng, H. Xiao, C. Huang, J Hu, W. Yao, G. Yu, W. Xiao, H. Xu,and Z. Ye, <strong><em>Regulation of glucosemetabolism by p62/SQSTM1 through HIF1α</em></strong><em>.</em> J Cell Sci, 2016. 129(4): p.817-830.</div></div><h4 class="publication-year">2015</h4><div class="w-layout-blockcontainer container-3 w-container"><div class="paper-list">1. H Xiao, K Tang, P Liu, K Chen, <strong>J Hu</strong>, J Zeng, W Xiao, G Yu, W Yao, H Zhou,H Li, Y Pan, A Li, Z Ye, J Wang, H Xu, Q Huang. <strong><em>LncRNA MALAT1 functions as acompeting endogenous RNA to regulate ZEB2 expression by sponging miR-200s inclear cell kidney carcinoma</em></strong>. Oncotarget. 2015 Nov 10;6(35):38005-15.</div><div class="paper-list">2. H Xiao., J. Zeng, H. Li, K. Chen, G. Yu,<strong>J Hu</strong>, K. Tang, H. Zhou, Q. Huang,and A. Li, <strong><em>MiR-1 downregulationcorrelates with poor survival in clear cell renal cell carcinoma where itinterferes with cell cycle regulation and metastasis</em></strong><em>.</em> Oncotarget, 2015. 6(15): p. 13201-13215.</div></div><h4 class="publication-year">2014</h4><div class="w-layout-blockcontainer container-3 w-container"><div class="paper-list">1. H Xiao,H. Li, G. Yu, W. Xiao, <strong>J Hu</strong>, K.Tang, J. Zeng, W. He, G. Zeng, and Z. Ye, <strong><em>MicroRNA-10bpromotes migration and invasion through KLF4 and HOXD10 in human bladder cancer</em></strong><em>. </em>Oncology reports, 2014. 31(4): p. 1832-1838.</div><div class="paper-list">2. C Wang, Z. Chen, Q. Ge, <strong>J Hu</strong>, F. Li, J. Hu, H. Xu, Z. Ye, and L.-C. Li, <strong><em>Up‐regulation ofp21WAF1/CIP1 by miRNAs and its implications in bladder cancer cells.</em></strong> FEBS Letters,2014. 588(24): p. 4654-4664.</div><div class="paper-list">3. G Yu, H. Li, J. Wang, K. Gumireddy, A.Li, W. Yao, K. Tang, W. Xiao, <strong>J. Hu</strong>,and H. Xiao, <strong><em>miRNA-34a suppresses cellproliferation and metastasis by targeting CD44 in human renal carcinoma cells</em></strong><em>. </em>Journal of Urology, 2014. 192(4):p. 1229-1237.</div></div></div></div></section><section class="footer-light"><div class="container-5"><div class="footer-wrapper-two"><a href="https://demo-8cc0ce.webflow.io/#" class="footer-brand w-inline-block"><img src="./Demo_files/65add0c6b170ad460824b814_logo2.fw.png" loading="lazy" width="80" alt="" class="image-6"></a></div><div class="footer-bottom"><div class="footer-copyright">© 2024 Hu Botanical Garden. All rights reserved</div></div></div></section><script src="./Demo_files/jquery-3.5.1.min.dc5e7f18c8.js.download" type="text/javascript" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous"></script><script src="./Demo_files/webflow.schunk.47fd547f44146dd0.js.download" type="text/javascript"></script><script src="./Demo_files/webflow.a9ba356d.7fed694de9ff0cad.js.download" type="text/javascript"></script></body></html>